Hospital Sant Joan de Déu Barcelona is a teaching hospital specializing in the fields of pediatrics, gynecology and obstetrics. It is located on Passeig Sant Joan de Déu in Esplugues de Llobregat, a municipality bordering Barcelona, Catalonia.

During the past decade, Hospital Sant Joan de Deu; Servicio de Oncologia y Hematologia conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hospital Sant Joan de Deu; Servicio de Oncologia y Hematologia" are "CNS Tumors" (1 trials), "Severe Hemophilia A" (1 trials) and "Solid Tumors" (1 trials). Many other conditions were trialed in "Hospital Sant Joan de Deu; Servicio de Oncologia y Hematologia" in a lesser frequency.

Most popular intervention types in "Hospital Sant Joan de Deu; Servicio de Oncologia y Hematologia" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Emicizumab" (1 trials) and "Entrectinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Sant Joan de Deu; Servicio de Oncologia y Hematologia" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Sant Joan de Deu; Servicio de Oncologia y Hematologia". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Hospital Sant Joan de Deu; Servicio de Oncologia y Hematologia, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Sant Joan de Deu; Servicio de Oncologia y Hematologia, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".